NASDAQ:PSNLPersonalis Stock Price, Forecast & News

Personalis' stock was trading at $6.02 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PSNL stock has increased by 136.0% and is now trading at $14.21. View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Personalis in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Personalis.

Personalis is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for Personalis.

Personalis (NASDAQ:PSNL) announced its quarterly earnings data on Thursday, May, 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by $0.03. The business had revenue of $19.16 million for the quarter, compared to analyst estimates of $16.80 million. Personalis had a negative return on equity of 26.28% and a negative net margin of 40.60%. View Personalis' earnings history.

5 Wall Street analysts have issued 12 month price objectives for Personalis' stock. Their forecasts range from $14.00 to $29.00. On average, they expect Personalis' stock price to reach $22.25 in the next year. This suggests a possible upside of 56.6% from the stock's current price. View analysts' price targets for Personalis.

Media stories about PSNL stock have trended negative recently, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Personalis earned a news impact score of -2.8 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 7.0 out of 10, indicating that recent press coverage is likely to have an impact on the stock's share price in the next few days. View the latest news about Personalis.

Personalis saw a drop in short interest in the month of June. As of June 15th, there was short interest totaling 895,500 shares, a drop of 15.5% from the May 31st total of 1,060,000 shares. Based on an average trading volume of 365,200 shares, the days-to-cover ratio is presently 2.5 days. Currently, 5.7% of the shares of the company are sold short. View Personalis' Current Options Chain.

Some companies that are related to Personalis include CareDx (CDNA), Veracyte (VCYT), RadNet (RDNT), Castle Biosciences (CSTL), Centogene (CNTG), Fulgent Genetics (FLGT), DermTech (DMTK), Enzo Biochem (ENZ), Biocept (BIOC), Celcuity (CELC), Anpac Bio-Medical Science (ANPC), Miragen Therapeutics (MGEN), Psychemedics (PMD), OpGen (OPGN) and Avant Diagnostics (AVDX). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Personalis investors own include Editas Medicine (EDIT), Canopy Growth (CGC), Ford Motor (F), Flexion Therapeutics (FLXN), Proteostasis Therapeutics (PTI), Enphase Energy (ENPH), Energy Transfer LP Unit (ET), Inovio Pharmaceuticals (INO), NIO (NIO) and Viking Therapeutics (VKTX).

(PSNL) raised $100 million in an IPO on Thursday, June 20th 2019. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, BofA Merrill Lynch and Cowen and Company acted as the underwriters for the IPO and Oppenheimer was co-manager.

Personalis trades on the NASDAQ under the ticker symbol "PSNL."

Shares of PSNL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PSNL stock can currently be purchased for approximately $14.21.

Personalis has a market capitalization of $450.60 million and generates $65.21 million in revenue each year. The company earns $-25,080,000.00 in net income (profit) each year or ($1.39) on an earnings per share basis. Personalis employs 181 workers across the globe.

The official website for Personalis is www.personalis.com.

Personalis' mailing address is 1330 O`BRIEN DRIVE, MENLO PARK CA, 94025. The company can be reached via phone at 650-752-1300 or via email at [email protected]